Method for testing bioactivities of GLP-1 receptor agonist
Patent Information
- Authority / Receiving Office
- CN Β· China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SHANGHAI HUAYI BIO LAB CO LTD
- Publication Date
- 2010-08-11
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a biological activity assay method, more specifically to a biological activity assay method of a GLP-1 receptor agonist. Background technique
[0002] Diabetes has become a major disease that threatens human life and health, and GLP-1 receptor agonists occupy an increasingly important position in diabetes drug research [Drug Review. 2009, 24(1): 32-33; Drug Review. 2008, 5(11):504-505]; GLP-1 receptor agonists mainly include glucagon-like peptide-1 (GLP-1), insulin-secreting peptide (Exendin-4), human GLP-1 analogues For Liraglutide, the determination of its biological activity has become a major difficulty because there is no international standard for activity determination [Chinese Journal of Biological Products. 2004, 17(1): 29-31].
[0003] The biological function of GLP-1 receptor agonists is mainly to specifically interact with the GLP-1 receptor of islet cells, causing changes in the corresponding signaling pathways an...